Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31332153 | 0.87 | CHRNB2 (0.41) | CHRNB2CHRNA4PKN2SIGMAR1HTR2C | |
| SCHEMBL844869 | 0.77 | SIGMAR1 (0.42) | CHRNB2CHRNA4SIGMAR1 | |
| SCHEMBL2589655 | 0.75 | CD44 (0.45) | HTR2C | |
| Hydrochloric Acid SCHEMBL5849050 | 0.74 | CD44 (0.44) | HTR2C | |
| SCHEMBL13786480 | 0.72 | CHRNB2 (0.37) | CHRNB2CHRNA4SIGMAR1 | |
| SCHEMBL31332380 | 0.68 | SLC40A1 (0.31) | — | |
| SCHEMBL2565015 | 0.67 | CHRNB2 (0.77) | CHRNB2CHRNA4PKN2SIGMAR1 | |
| SCHEMBL587887 | 0.67 | CHRNB2 (0.77) | CHRNB2CHRNA4PKN2SIGMAR1HTR2C | |
| SCHEMBL30183351 | 0.67 | CHRNB2 (0.77) | CHRNB2CHRNA4PKN2SIGMAR1 | |
| SCHEMBL29850369 | 0.67 | CHRNB2 (0.77) | CHRNB2CHRNA4PKN2SIGMAR1HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025011580-A1 | COMPOUND FOR TREATING AND PREVENTING RESPIRATORY SYNCYTIAL VIRUS INFECTION DISEASES | 石药集团中奇制药技术（石家庄）有限公司 | 2025-01-16 | — | — | WO | disclosed |
| CN-119285628-A | Compounds for the treatment and prophylaxis of respiratory syncytial virus infection diseases | 石药集团中奇制药技术（石家庄）有限公司 | 2025-01-10 | — | — | CN | disclosed |